Eprontia Prices, Coupons and Patient Assistance Programs
Eprontia (topiramate) is a member of the carbonic anhydrase inhibitor anticonvulsants drug class and is commonly used for Epilepsy, Lennox-Gastaut Syndrome, Migraine Prevention, and others.
The cost for Eprontia oral solution (25 mg/mL) is around $780 for a supply of 473 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Eprontia is available as a brand name drug only, a generic version is not yet available. View generic Eprontia availability for more details.
Eprontia prices
Oral Solution
Quantity | Per unit | Price |
---|---|---|
473 milliliters | $1.65 | $779.76 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Eprontia Coupons, Copay Cards and Rebates
Eprontia offers may be in the form of a printable coupon, rebate, savings or copay card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Eprontia eVocherRx Program: Eligible commercially insured patients may pay $0 per prescription at a participating pharmacy; for additional information contact the program at 844-472-2032.
- Applies to:
- Eprontia
- Number of uses:
- Per prescription until program expires
Form more information phone: 844-472-2032 or Visit website
Eprontia Bridge Drug Program: Eligible commercially insured patients experiencing an insurance delay longer than 48 hours may be able to provide up to 30 days of medication at no cost; for additional information contact the program at 844-472-2032.
- Applies to:
- Eprontia
- Number of uses:
- Temporary Assistance
Form more information phone: 844-472-2032 or Visit website
Patient Assistance & Copay Programs for Eprontia
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines and copay programs to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Eprontia (topiramate) Solution; Oral
More information please phone: 866-316-7263 Visit Website
Provider: Azurity Solutions: Eprontia
Elligibility requirements:- Determined case by case
- Based on FPL
- Medically Necessary as determined by a Doctor
- Must be treated by US licensed healthcare provider
- Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Eprontia (topiramate) Solution; Oral
More information please phone: 844-472-2032 Visit Website
More about Eprontia (topiramate)
- Check interactions
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
Other brands
Topamax, Trokendi XR, Topiragen, Topamax Sprinkle, Qudexy XR